CREM and neoplasm: More recently, CREM, has also been identified as a transcriptional checkpoint in natural killer (NK) cells, where its deletion enhances CAR-NK cell anti-tumor efficacy by derepressing key effector genes such as PRF1 and GZMB, implicating this pathway in broader immunoregulatory functions (Rafei et al., 2025).